Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Inoviq Ltd ( (AU:IIQ) ) has provided an announcement.
Inoviq Ltd has notified the market of the issue of 700,000 unquoted options under its employee incentive scheme, recorded as Appendix 3G with the ASX. The options, which have various expiry dates and exercise prices and are not intended to be quoted on the exchange, form part of Inoviq’s remuneration and retention strategy for staff, underscoring the company’s use of equity-based incentives to align employees with long-term shareholder value and operational goals.
The most recent analyst rating on (AU:IIQ) stock is a Hold with a A$0.37 price target. To see the full list of analyst forecasts on Inoviq Ltd stock, see the AU:IIQ Stock Forecast page.
More about Inoviq Ltd
Inoviq Ltd is an Australian-listed company on the ASX (code: IIQ). The company operates within the broader life sciences and biotechnology sector, focusing on the development and commercialisation of diagnostic technologies and related products, primarily targeting healthcare and medical markets.
Average Trading Volume: 172,672
Technical Sentiment Signal: Sell
Current Market Cap: A$53.49M
Find detailed analytics on IIQ stock on TipRanks’ Stock Analysis page.